First published 9/28/2026, 6:01:15 AM · Last updated 9/28/2026, 6:01:30 AM

Du-Shu-Wan alleviates Tau protein phosphorylation in Alzheimer's disease by regulating MAPK/JNK signaling pathway

A peer-reviewed journal article published by Elsevier BV reports that the herbal formulation Du-Shu-Wan reduces Tau protein phosphorylation in Alzheimer's disease through modulation of the MAPK/JNK signaling pathway. The source record provided is the article title and publisher with a publication date of 2027-02-01.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The study describes a potential molecular mechanism by which Du-Shu-Wan could affect a pathological feature of Alzheimer's disease.

Sources

Du-Shu-Wan alleviates Tau protein phosphorylation in Alzheimer's disease by regulating MAPK/JNK signaling pathway

Report an issue